Categories: Business

CJ 4DPLEX Achieves Record-Breaking May Box Office in North America

LOS ANGELES, June 6, 2025 /PRNewswire/ — CJ 4DPLEX, the world’s leading producer of premium film formats, announced today the company’s highest-ever domestic box office results for the month of May in both 4DX and SCREENX formats.

- Advertisement -

4DX generated $9.4 million in North America for the month, up 151% year-over-year. And SCREENX also posted a record performance with $4.6 million in box office revenue, up 112% over the same period last year, for a combined total of $14M across both formats. CJ 4DPLEX also had a global record box office with a combined total of $38.4M, up 61% from last May.

- Advertisement -

“This record-breaking May reflects how audiences continue to embrace premium, immersive formats as the ultimate way to experience blockbuster films,” said Don Savant, CEO & President, CJ 4DPLEX America. “Whether it’s the thrilling stunts of Mission: Impossible, the family adventure of Lilo & Stitch, or the chilling scares of Final Destination: Bloodlines, 4DX and SCREENX continue to deliver unforgettable moments that can only happen in theaters.”

- Advertisement -

CJ 4DPLEX’s 4DX format enhances films with environmental effects such as motion, vibration, wind, fog, lightning, and scent, fully synchronized to the on-screen action. SCREENX expands select sequences onto the side walls of the auditorium, creating up to 270 degrees of panoramic, immersive visuals.

- Advertisement -

About CJ 4DPLEX

- Advertisement -

CJ 4DPLEX is a leading, next-generation cinema technology company, headquartered in Seoul with international offices in Los Angeles and Beijing. The company has created innovative film technologies for theaters worldwide that include ‘SCREENX’, ‘4DX’, and ‘Ultra 4DX’ for consumers to experience films in ways that were never before possible.

- Advertisement -

CJ 4DPLEX is a part of the CJ Group conglomerate that also includes entertainment powerhouses CJ CGV, the fifth largest theater chain in the world, and CJ ENM (CJ Entertainment & Media), who produced the Academy Award®, Golden Globe® and SAG Awards winning film, “Parasite”.

- Advertisement -

SCREENX is the world’s first multi-projection cinema with an immersive 270 degree field of view. By expanding the image beyond the frame and onto the walls of the theater, SCREENX places the audience directly at the center of the story, creating a visually immersive viewing experience unlike any other. To date, there are over 435 SCREENX auditoriums around the world in 48 countries.

- Advertisement -

4DX provides moviegoers with a multi-sensory cinema-going experience, allowing audiences to connect with movies through motion, vibration, water, wind, snow, lightning, scents, and other special effects that enhance the visuals on-screen. Each 4DX auditorium incorporates motion-based seating synchronized with more than 21 different effects and optimized by a team of skilled editors. To date, there are over 775 4DX auditoriums around the world, spanning over 70 countries.

- Advertisement -

Logo – https://mma.prnewswire.com/media/1821085/CJ_4DPLEX_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cj-4dplex-achieves-record-breaking-may-box-office-in-north-america-302474913.html

- Advertisement -
PRNW Agency

Recent Posts

Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated

ZUG, Switzerland, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Ms. Kazem brings extensive and global expertise…

5 days ago

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

2 weeks ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

2 weeks ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago